SMG Stock Recent News

The U.S. cannabis industry continues to expand rapidly. Experts estimate the market will exceed $45 billion in annual revenue by 2025. This growth is fueled by consumer demand, increasing dispensary presence, and employment surges across cultivation and retail sectors. Most Americans now live near a licensed cannabis store, and the industry employs hundreds of thousands. While federal legalization remains pending, significant momentum is building. Recent federal efforts to reclassify cannabis could reduce restrictions and tax burdens. These changes would directly benefit ancillary businesses supporting cultivation and distribution. Therefore, many investors are closely watching this space for early opportunities.

Most cannabis stock investors are stuck in a unique position in the sector. To start, most publicly traded cannabis companies are down and have been for some time. With all that is occurring across the stock market due to the tariffs, new concerns are further to grow. No one knows exactly how this will impact marijuana stocks and the future of the cannabis industry. People are trying to make the best choices on where to stay calm, cut their losses, or double down on how low the sector has fallen.

Under the terms of the agreement, SMG transfers The Hawthorne Collective in exchange for an interest-bearing promissory note.

Scotts Miracle-Gro is moving to separate its cannabis holdings from its core business, at least until the drug moves closer to federal legalization.

Transfer of Hawthorne Collective reflects focus on separating cannabis holdings and driving greater growth in core lawn and garden business Transfer of Hawthorne Collective reflects focus on separating cannabis holdings and driving greater growth in core lawn and garden business

MARYSVILLE, Ohio, April 10, 2025 (GLOBE NEWSWIRE) -- To connect more children to gardens and outdoor play, The Scotts Miracle-Gro Foundation and KidsGardening are awarding grants to 170 community-level programs under the annual GroMoreGood Grassroots Grant initiative.

Jefferies upgraded Scotts Miracle-Gro to Buy from Hold with a price target of $69, down from $72. The firm says that with 5% of the company's cost of goods sold exposed to tariffs, lawn and garden spend being "resilient" during economic contractions, and a potential tailwind as households trade-down from do-it-for-me to do-it-yourself, it has confidence in Scotts Miracle-Gro's fiscal 2025 EBITDA growth view. In 2025, Jefferies believes stocks with little international sourcing exposure and "defensive" business models as quality "hide-outs" for alpha. Scotts "checks those boxes," the firm contends.

The U.S. cannabis industry is experiencing significant growth, with legal sales projected to reach around $45 billion in 2025. Wider legalization efforts and increased consumer demand fuel this rapid expansion. Today, most Americans live in areas with at least one licensed dispensary. Recently, there has also been renewed momentum toward federal cannabis reform, with new legalization initiatives gaining traction. As these trends continue, ancillary cannabis companies are becoming key players. They supply the tools, technologies, and services that drive the industry forward without touching the plant directly.

Scotts (SMG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Marijuana stocks are still trading at low levels, making it tough to find the silver lining as an investor. Yet, the overall progress and success for companies as businesses are doing well. This is due to more people wanting more cannabis products. This leads to more sales and a bigger demand that, as of now, is continuously growing. The success of the industry is what is building a large amount of speculation about what may take place in the future.